Literature DB >> 21544845

Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1α via epidermal growth factor receptor-mediated signaling pathways.

Hongmei Yu1, Qi Li, Victor P Kolosov, Juliy M Perelman, Xiangdong Zhou.   

Abstract

Cigarette smoking is strongly implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). Mucus hypersecretion is the key manifestation in patients with COPD and mucin 5AC (MUC5AC) is a major component of airway mucus. Hypoxia inducible factor-1 (HIF-1) is a transcriptional factor which can be stimulated to bind to the MUC5AC promoter and induce MUC5AC promoter activation. Previous studies have reported that activation of HIF-1α pathways by cigarette smoke contributes to the development of COPD. We hypothesize that cigarette smoke up-regulates HIF-1α production and HIF-1 activity through epidermal growth factor receptor (EGFR)-activated signal cascades pathways, leading to mucin production in human airway epithelial cells (16HBE). We show that cigarette smoke increases HIF-1α production, HIF-1 activity and MUC5AC expression. These effects are prevented by small interfering RNA (siRNA) for HIF-1α, indicating that cigarette smoke-induced mucin production is HIF-1α-dependent. Cigarette smoke activates extracellular signal-regulated kinase 1/2 (ERK1/2) and phosphatidylinositol 3-kinase (PI3K) signal pathways, both of which are inhibited by gefitinib (an inhibitor of EGFR), suggesting that cigarette smoke-activated signal pathways are mediated by EGFR in 16HBE cells. Furthermore, pretreatment with gefitinib and the pharmacological inhibitors of PI3K (LY294002) and ERK1/2 (PD98059) prevented cigarette smoke-mediated Akt and ERK1/2 phosphorylation responses, HIF-1α production, HIF-1 activity and MUC5AC expression. These observations demonstrate an important role for EGFR-mediated signaling pathways in regulating cigarette smoke-induced HIF-1 activation and MUC5AC expression. Our results suggest that cigarette smoke activates EGFR-mediated signaling pathways, leading to HIF-1α production and HIF-1 activation, resulting in mucin expression in human airway epithelial cells.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544845     DOI: 10.1002/jat.1679

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  18 in total

1.  High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.

Authors:  Renzhong Li; Lalita Uttarwar; Bo Gao; Martine Charbonneau; Yixuan Shi; John S D Chan; Claire M Dubois; Joan C Krepinsky
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

2.  A chronic obstructive pulmonary disease negatively influences the prognosis of patients with bladder urothelial carcinoma via hypoxia inducible factor-1α.

Authors:  Zhichao Huang; Ran Xu; Chen Lv; Zhaohui Zhong; Lei Zhang; Liang Zhu; Yongzhong Tang; Xiaokun Zhao
Journal:  Int J Clin Exp Med       Date:  2014-10-15

3.  Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.

Authors:  A Joseph Bloom; Timothy B Baker; Li-Shiun Chen; Naomi Breslau; Dorothy Hatsukami; Laura J Bierut; Alison Goate
Journal:  Hum Mol Genet       Date:  2013-09-17       Impact factor: 6.150

Review 4.  Targeting mucus hypersecretion: new therapeutic opportunities for COPD?

Authors:  Clémence Martin; Justine Frija-Masson; Pierre-Régis Burgel
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 5.  Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view.

Authors:  Shiv Ram Krishn; Koelina Ganguly; Sukhwinder Kaur; Surinder K Batra
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

6.  Mucus composition abnormalities in sinonasal mucosa of chronic rhinosinusitis with and without nasal polyps.

Authors:  Yanyi Tu; Jing Liu; Tao Li; Xiangmin Zhou; Kai Sen Tan; Hsiao Hui Ong; Kaiyue Sun; Yi Ouyang; Xu Liang; Yew Kwang Ong; Mark Thong; Li Shi; De-Yun Wang
Journal:  Inflammation       Date:  2021-05-17       Impact factor: 4.092

7.  Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation.

Authors:  Sunhyae Jang; Ji Won Park; Hye Rim Cha; Sun Young Jung; Jeong Eun Lee; Sung Soo Jung; Ju Ock Kim; Sun Young Kim; Choong Sik Lee; Hee Sun Park
Journal:  Int J Nanomedicine       Date:  2012-03-14

Review 8.  Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?

Authors:  Meiling Liu; Kang Wu; Jinduan Lin; Qingqiang Xie; Yuan Liu; Yin Huang; Jun Zeng; Zhaogang Yang; Yifan Wang; Shiyan Dong; Weiye Deng; Mingming Yang; Song Wu; Wen Jiang; Xuefeng Li
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

9.  A simple and rapid method for standard preparation of gas phase extract of cigarette smoke.

Authors:  Tsunehito Higashi; Yosuke Mai; Yoichi Noya; Takahiro Horinouchi; Koji Terada; Akimasa Hoshi; Prabha Nepal; Takuya Harada; Mika Horiguchi; Chizuru Hatate; Yuji Kuge; Soichi Miwa
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

10.  Identification of non-coding genetic variants in samples from hypoxemic respiratory disease patients that affect the transcriptional response to hypoxia.

Authors:  Olga Roche; María Laura Deguiz; María Tiana; Clara Galiana-Ribote; Daniel Martinez-Alcazar; Carlos Rey-Serra; Beatriz Ranz-Ribeiro; Raquel Casitas; Raúl Galera; Isabel Fernández-Navarro; Silvia Sánchez-Cuéllar; Virginie Bernard; Julio Ancochea; Wyeth W Wasserman; Francisco García-Rio; Benilde Jimenez; Luis Del Peso
Journal:  Nucleic Acids Res       Date:  2016-09-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.